Clinical Trial Update: A Phase IV Study to Assess the Safety of EupentaTM Inj [Phase 4]

View source ↗

Summary

Phase IV study update assessing the safety of EupentaTM Inj; the document lists multiple conditions and an unknown status for the trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Haemophilus Influenzae Type Infection
• Hepatitis B
• Pertussis
• Tetanus

Drugs mentioned

• EupentaTM Inj

Snippet

Sponsor: LG Chem | Conditions: Hepatitis B, Diphtheria | Phase 4 | Status: UNKNOWN